Submitted:
15 July 2026
Posted:
22 July 2026
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Patient Population
2.2. Treatment Allocation and Patient Counseling
2.3. Surgical Technique
2.4. Outcome Definitions and Follow-Up
2.5. Statistical Analysis
3. Results
3.1. Baseline Characteristics
3.2. Surgical and Postoperative Outcomes
3.3. Recurrence


3.4. Recurrence Risk Stratification
3.5. Multivariable Analysis
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Guner, A.; et al. Limberg flap versus Bascom cleft lift for pilonidal sinus. World J. Surg. 2013, 37, 2074–80. [Google Scholar] [CrossRef] [PubMed]
- Doll, D.; et al. Surgery for asymptomatic pilonidal sinus disease. Int. J. Colorectal Dis. 2008, 23, 839–44. [Google Scholar] [CrossRef] [PubMed]
- Enriquez-Navascues, J.M.; et al. Meta-analysis of RCTs for chronic pilonidal sinus. Tech Coloproctol. 2014, 18, 863–72. [Google Scholar] [CrossRef] [PubMed]
- de Parades, V.; et al. Pilonidal sinus disease. J. Visc. Surg. 2013, 150, 237–47. [Google Scholar] [CrossRef] [PubMed]
- Stauffer, V.K.; et al. Common surgical procedures in pilonidal sinus: a meta-analysis. Sci. Rep. 2018, 8, 3058. [Google Scholar] [CrossRef] [PubMed]
- Bascom, J. Pilonidal disease: long-term results of follicle removal. Dis. Colon Rectum 1983, 26, 800–7. [Google Scholar] [CrossRef] [PubMed]
- Gips, M.; et al. Minimal surgery for pilonidal disease using trephines. Dis. Colon Rectum 2008, 51, 1656–62. [Google Scholar] [CrossRef] [PubMed]
- Di Castro, A.; et al. Minimally invasive surgery for pilonidal disease. The Gips procedure on 2347 patients. Int. J. Surg. 2016, 36, 201–5. [Google Scholar] [CrossRef] [PubMed]
- Meinero, P.; et al. Endoscopic pilonidal sinus treatment. Tech Coloproctol. 2014, 18, 389–92. [Google Scholar] [PubMed]
- Milone, M.; et al. Video-assisted ablation of pilonidal sinus. Surgery 2014, 155, 562–6. [Google Scholar] [CrossRef] [PubMed]
- Dessily, M.; et al. Pilonidal sinus destruction with a radial laser probe. Acta Chir. Belg. 2017, 117, 164–8. [Google Scholar] [CrossRef] [PubMed]
- Emile, S.H.; et al. Endoscopic pilonidal sinus treatment: systematic review. Surg. Endosc. 2018, 32, 3754–62. [Google Scholar] [CrossRef] [PubMed]
- Milone, M.; et al. Long-term results of a RCT comparing endoscopic versus conventional treatment. Int. J. Surg. 2020, 74, 81–5. [Google Scholar] [CrossRef] [PubMed]
- Huurman, E.A.; et al. Non-excisional techniques for intergluteal pilonidal sinus: systematic review. Tech Coloproctol. 2023, 27, 1191–1200. [Google Scholar] [CrossRef] [PubMed]
- Lorant, T.; et al. Sinus excision and primary closure versus laying open in pilonidal disease. Dis. Colon Rectum 2011, 54, 300–5. [Google Scholar] [CrossRef] [PubMed]
- Tezel, E. A new classification for sacrococcygeal pilonidal disease. Colorectal Dis. 2007, 9, 575–6. [Google Scholar] [CrossRef] [PubMed]




| Variable | Pit-Picking + MWA (n=200) | Pit-Picking Alone (n=203) | p-Value |
| Age, median (IQR), years | 24 (20–29) | 25 (20–30) | 0.428 |
| Male sex, n (%) | 130 (65.0%) | 129 (63.5%) | 0.751 |
| BMI, mean ± SD (kg/m²) | 25.9 ± 3.4 | 26.1 ± 3.5 | 0.364 |
| Family history, n (%) | 28 (14.0%) | 27 (13.3%) | 0.842 |
| Symptom duration, median (IQR), months | 8 (4–14) | 9 (4–15) | 0.291 |
| Previous abscess drainage, n (%) | 49 (24.5%) | 53 (26.1%) | 0.702 |
| Smoking, n (%) | 90 (45.0%) | 90 (44.3%) | 0.889 |
| Tezel classification, n (%) | |||
| Class III | 122 (61.0%) | 122 (60.1%) | 0.854 |
| Class IV | 55 (27.5%) | 57 (28.0%) | 0.913 |
| Class V | 23 (11.5%) | 24 (11.9%) | 0.902 |
| Follow-up, median (IQR), months | 16 (12–22) | 16 (12–21) | 0.812 |
| Outcome | Pit-Picking + MWA (n=200) | Pit-Picking Alone (n=203) | p-Value | OR (95% CI) |
| Operative time, median (IQR), min | 22 (18–27) | 15 (12–19) | <0.001 | — |
| Overall complication, n (%) | 9 (4.5%) | 23 (11.3%) | 0.018 | 0.37 (0.16–0.84) |
| Surgical site infection, n (%) | 3 (1.5%) | 11 (5.4%) | 0.031 | 0.26 (0.07–0.95) |
| VAS score at 24 h, median (IQR) | 2 (1–3) | 4 (3–5) | <0.001 | — |
| VAS score at day 7, median (IQR) | 0 (0–1) | 2 (1–3) | <0.001 | — |
| Time to pain-free sitting, median (IQR), days | 2 (1–3) | 4 (3–6) | <0.001 | — |
| Complete wound healing, median (IQR), days | 11 (9–14) | 16 (13–20) | <0.001 | — |
| Return to work, median (IQR), days | 3 (2–4) | 5 (4–7) | <0.001 | — |
| Recurrence, n (%) | 11 (5.5%) | 28 (13.8%) | 0.006 | 0.36 (0.17–0.75) |
| Variable | p-Value | Adjusted OR | 95% CI |
| Pit-picking + MWA (vs. pit-picking alone) | 0.007 | 0.35 | 0.16–0.76 |
| Tezel Class V (vs. Class III) | 0.032 | 2.81 | 1.09–7.25 |
| Previous abscess drainage | 0.041 | 2.14 | 1.03–4.42 |
| Smoking | 0.118 | 1.62 | 0.88–2.99 |
| Age (per year) | 0.214 | 1.03 | 0.98–1.08 |
| BMI (per kg/m²) | 0.387 | 1.04 | 0.95–1.14 |
| Male sex | 0.502 | 1.24 | 0.65–2.38 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).